115 related articles for article (PubMed ID: 2859424)
1. Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer.
A'Hern RP; Wilson AJ; Baum M
Lancet; 1985 Apr; 1(8435):976. PubMed ID: 2859424
[No Abstract] [Full Text] [Related]
2. Tamoxifen therapy in advanced breast cancer with positive estrogen receptors in postmenopausal women.
Bono A; Fariselli G; Bettoni I; Alloisio M; Nicoli N; Di Pietro S
Tumori; 1982 Apr; 68(2):143-7. PubMed ID: 7123673
[No Abstract] [Full Text] [Related]
3. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.
Rose C; Thorpe SM; Andersen KW; Pedersen BV; Mouridsen HT; Blichert-Toft M; Rasmussen BB
Lancet; 1985 Jan; 1(8419):16-9. PubMed ID: 2856949
[TBL] [Abstract][Full Text] [Related]
4. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
[TBL] [Abstract][Full Text] [Related]
5. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.
Gaskell DJ; Hawkins RA; Sangsterl K; Chetty U; Forrest AP
Lancet; 1989 May; 1(8646):1044-6. PubMed ID: 2566000
[TBL] [Abstract][Full Text] [Related]
6. [Tamoxifen therapy in locally advanced primary and recurrent breast cancer (author's transl)].
Wada T; Koyama H; Takahashi Y; Nishizawa Y; Iwanaga T; Aoki Y; Terasawa T
Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):819-24. PubMed ID: 501187
[No Abstract] [Full Text] [Related]
7. Activated oestrogen receptors in breast cancer and response to endocrine therapy.
Fernandez MD; Burn JI; Sauven PD; Parmar G; White JO; Myatt L
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):41-6. PubMed ID: 6537914
[TBL] [Abstract][Full Text] [Related]
8. The value of determination of nuclear oestrogen receptors in breast cancer biopsies.
Cowan S; Love C; Leake RE
Recent Results Cancer Res; 1984; 91():50-60. PubMed ID: 6729228
[No Abstract] [Full Text] [Related]
9. The role of adjuvant endocrine therapy in primary breast cancer.
Baum M; Ebbs SR
Recent Results Cancer Res; 1989; 115():136-43. PubMed ID: 2696026
[No Abstract] [Full Text] [Related]
10. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
[No Abstract] [Full Text] [Related]
11. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Morgan LR
Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
[TBL] [Abstract][Full Text] [Related]
12. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.
Campbell FC; Blamey RW; Elston CW; Morris AH; Nicholson RI; Griffiths K; Haybittle JL
Lancet; 1981 Dec; 2(8259):1317-9. PubMed ID: 6118718
[TBL] [Abstract][Full Text] [Related]
13. Anti-estrogen therapy for breast cancer: focus on tamoxifen.
Flynn KT; Durivage HJ
Oncol Nurs Forum; 1982; 9(4):21-5. PubMed ID: 6923414
[No Abstract] [Full Text] [Related]
14. [Tamoxifen-induced progesterone receptors in breast tumors].
Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
[TBL] [Abstract][Full Text] [Related]
15. Results with tamoxifen in advanced mammary carcinoma.
Kolb R; Jakesz R; Reiner H
Recent Results Cancer Res; 1980; 71():146-8. PubMed ID: 7367726
[TBL] [Abstract][Full Text] [Related]
16. [7 years' experience in the determination of hormone receptors in cancer of the breast. Current status and prospectives for the surgeon].
Pietrarota P; Battistoni MG; Caprioli F
Pathologica; 1987; 79(1059-1060):105-8. PubMed ID: 3441400
[No Abstract] [Full Text] [Related]
17. Use of aminoglutethimide for the treatment of advanced breast cancer. Clinical correlations with previous treatment, oestrogen-receptor and menstrual status.
Bezwoda WR; Dansey RD; Hesdorffer CS; Browde S
S Afr Med J; 1987 Jul; 72(2):107-9. PubMed ID: 3616780
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapy.
De Lena M; Brambilla C; Jirillo A
Tumori; 1980 Jun; 66(3):339-48. PubMed ID: 7445113
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contents.
Westerberg H; Nordenskjold B; Wrange O; Gustafsson JA; Humla S; Theve NO; Silfverswärd C; Granberg PO
Eur J Cancer (1965); 1978 Jun; 14(6):619-22. PubMed ID: 658084
[No Abstract] [Full Text] [Related]
20. The estrogen receptor and the progesterone receptor in Chinese breast cancer.
Liu TJ; Chi CW; Wu LH
Taiwan Yi Xue Hui Za Zhi; 1984 Jan; 83(1):45-58. PubMed ID: 6586988
[No Abstract] [Full Text] [Related]
[Next] [New Search]